Ireland Patient-derived Xenograft Model Market (2025-2031) | Size & Revenue, Segmentation, Value, Competitive Landscape, Analysis, Companies, Outlook, Growth, Trends, Forecast, Share, Industry

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Ireland Country Macro Economic Indicators

3.2 Ireland Patient-derived Xenograft Model Market Revenues & Volume, 2021 & 2031F

3.3 Ireland Patient-derived Xenograft Model Market - Industry Life Cycle

3.4 Ireland Patient-derived Xenograft Model Market - Porter's Five Forces

3.5 Ireland Patient-derived Xenograft Model Market Revenues & Volume Share, By Tumor Type, 2021 & 2031F

3.6 Ireland Patient-derived Xenograft Model Market Revenues & Volume Share, By Model Type, 2021 & 2031F

3.7 Ireland Patient-derived Xenograft Model Market Revenues & Volume Share, By End-user, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing demand for personalized medicine and targeted therapies

4.2.2 Rising prevalence of cancer and other complex diseases in Ireland

4.2.3 Advancements in oncology research and drug development

4.3 Market Restraints

4.3.1 High cost associated with patient-derived xenograft models

4.3.2 Ethical concerns related to the use of animal models in research

4.3.3 Limited awareness and adoption of patient-derived xenograft models in Ireland

6.1 Ireland Patient-derived Xenograft Model Market, By Tumor Type

6.1.1 Overview and Analysis

6.1.2 Ireland Patient-derived Xenograft Model Market Revenues & Volume, By Tumor Type, 2021- 2031F

6.1.3 Ireland Patient-derived Xenograft Model Market Revenues & Volume, By Lung Cancer, 2021- 2031F

6.1.4 Ireland Patient-derived Xenograft Model Market Revenues & Volume, By Pancreatic Cancer, 2021- 2031F

6.1.5 Ireland Patient-derived Xenograft Model Market Revenues & Volume, By Prostate Cancer, 2021- 2031F

6.1.6 Ireland Patient-derived Xenograft Model Market Revenues & Volume, By Breast Cancer, 2021- 2031F

6.1.7 Ireland Patient-derived Xenograft Model Market Revenues & Volume, By Other Cancer, 2021- 2031F

6.2 Ireland Patient-derived Xenograft Model Market, By Model Type

6.2.1 Overview and Analysis

6.2.2 Ireland Patient-derived Xenograft Model Market Revenues & Volume, By Mice, 2021- 2031F

6.2.3 Ireland Patient-derived Xenograft Model Market Revenues & Volume, By Rats, 2021- 2031F

6.3 Ireland Patient-derived Xenograft Model Market, By End-user

6.3.1 Overview and Analysis

6.3.2 Ireland Patient-derived Xenograft Model Market Revenues & Volume, By Pharmaceutical and Biopharmaceutical Companies, 2021- 2031F

6.3.3 Ireland Patient-derived Xenograft Model Market Revenues & Volume, By Academic & Research Institutes, 2021- 2031F

6.3.4 Ireland Patient-derived Xenograft Model Market Revenues & Volume, By CROs & CDMOs, 2021- 2031F

7.1 Ireland Patient-derived Xenograft Model Market Export to Major Countries

7.2 Ireland Patient-derived Xenograft Model Market Imports from Major Countries

8.1 Time to engraftment of patient-derived xenograft models

8.2 Success rate of drug testing using patient-derived xenograft models

8.3 Number of collaborations between research institutions and pharmaceutical companies for PDX model research

9.1 Ireland Patient-derived Xenograft Model Market Opportunity Assessment, By Tumor Type, 2021 & 2031F

9.2 Ireland Patient-derived Xenograft Model Market Opportunity Assessment, By Model Type, 2021 & 2031F

9.3 Ireland Patient-derived Xenograft Model Market Opportunity Assessment, By End-user, 2021 & 2031F

10.1 Ireland Patient-derived Xenograft Model Market Revenue Share, By Companies, 2024

10.2 Ireland Patient-derived Xenograft Model Market Competitive Benchmarking, By Operating and Technical Parameters